SciClone Pharmaceuticals Inc:企業の戦略的SWOT分析

【英語タイトル】SciClone Pharmaceuticals Inc - Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C2528)・商品コード:DATA904C2528
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:31
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

SciClone Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

SciClone Pharmaceuticals Inc (SciClone), a subsidiary of Silver Biotech Investment Ltd, develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin) is an immunostimulatory agent indicated for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), sepsis, certain cancers, and as an immune system enhancer. SciClone also markets other pharmaceutical products in China including DC Bead, a product for the embolization of malignant hypervascularized tumors. It also has several drug candidates in various clinical development states intended for the treatment of cancer and cardiovascular diseases. The company has presence in Beijing and Shanghai in China; Hong Kong and Vietnam. SciClone is headquartered in Foster City, California, the US.

SciClone Pharmaceuticals Inc Key Recent Developments

Aug 09,2017: SciClone Reports Second Quarter 2017 Financial Results
May 10,2017: SciClone Reports First Quarter 2017 Financial Results
Mar 06,2017: SciClone Reports 2016 Financial Results And 2017 Outlook

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
SciClone Pharmaceuticals Inc – Key Facts 5
SciClone Pharmaceuticals Inc – Key Employees 6
SciClone Pharmaceuticals Inc – Key Employee Biographies 7
SciClone Pharmaceuticals Inc – Major Products and Services 8
SciClone Pharmaceuticals Inc – History 9
SciClone Pharmaceuticals Inc – Company Statement 11
SciClone Pharmaceuticals Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
SciClone Pharmaceuticals Inc – Business Description 16
SciClone Pharmaceuticals Inc – SWOT Analysis 17
SWOT Analysis – Overview 17
SciClone Pharmaceuticals Inc – Strengths 17
SciClone Pharmaceuticals Inc – Weaknesses 18
SciClone Pharmaceuticals Inc – Opportunities 19
SciClone Pharmaceuticals Inc – Threats 20
SciClone Pharmaceuticals Inc – Key Competitors 21
Section 3 – Company’s Lifesciences Financial Deals and Alliances 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 23
SciClone Pharmaceuticals Inc, Recent Deals Summary 24
Section 4 – Company’s Recent Developments 25
Aug 09, 2017: SciClone Reports Second Quarter 2017 Financial Results 25
May 10, 2017: SciClone Reports First Quarter 2017 Financial Results 27
Mar 06, 2017: SciClone Reports 2016 Financial Results And 2017 Outlook 29
Section 5 – Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
SciClone Pharmaceuticals Inc, Key Facts 5
SciClone Pharmaceuticals Inc, Key Employees 6
SciClone Pharmaceuticals Inc, Key Employee Biographies 7
SciClone Pharmaceuticals Inc, Major Products and Services 8
SciClone Pharmaceuticals Inc, History 9
SciClone Pharmaceuticals Inc, Subsidiaries 14
SciClone Pharmaceuticals Inc, Key Competitors 21
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 23
SciClone Pharmaceuticals Inc, Recent Deals Summary 24

List of Figures
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 23

★調査レポート[SciClone Pharmaceuticals Inc:企業の戦略的SWOT分析] (コード:DATA904C2528)販売に関する免責事項を必ずご確認ください。
★調査レポート[SciClone Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆